Navigation Links
Site-Specific Drug Delivery Market, By Application (Pulmonary, Ocular, Oncology, CNS, Cardiovascular) - World Forecasts to 2022
Date:1/3/2017

LONDON, Jan. 3, 2017 /PRNewswire/ -- The advent of site specific/targeted drug delivery has revolutionized the drug delivery industry. This technique is allowing a previously unattainable level of drug delivery with greater efficiency to target organs and tissues. Due to this ability, the share of site specific drug delivery is incessantly increasing in the drug delivery industry. It is anticipated that the global site specific drug delivery market will cross US$ 114 Billion by 2022. The growth of the market is likely to be driven by expanding drug discovery applications, rising chronic disease incidences, and increasing research related activities for exploring drug delivery therapeutic applications.

The report, "Site-Specific Drug Delivery Market, By Application (Pulmonary, Ocular, Oncology, CNS, Cardiovascular) - World Forecasts to 2022", provides an insight into the current and future prospective of this market. This report covers the major opportunities in this area, and drivers that have impact on the market. The report also discusses some of the challenges currently faced by the market.

The major application areas of targeted drug delivery pulmonary, ocular, oncology, and others including CNS, cardiovascular, etc. Oncology based application is the largest area of application of targeted drug delivery. This large share can be attributed to various research related activities conducted for developing targeted drug delivery approach for cancer.

Moreover, the report also contains the market share of major regions, including North America, Europe, and Asia Pacific. North America holds the largest market share, while Asia Pacific is expected to witness highest growth in the coming years, i.e. 2016-2022. The major reasons for the high growth are the ongoing researches in China and Australia, which is expanding therapeutic applications of site specific drug delivery to brain disorders. North America and Europe are expected to grow at a modest rate due to less stringent regulatory approval process and advancements in drug delivery technique.

The last segment of the report is entirely devoted to profiling leading companies of the targeted drug delivery industry, including some major players like Celgene Corporation, Arrowhead Pharma, Intezyne, Endocyte, BioDelivery Sciences International, PharmaIN, Mirus Bio, Savara, etc. This segment provides access to the financials, product portfolio, and recent developments of these companies. This segment also discusses the strengths and weaknesses of key players in this industry. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global site specific drug delivery market.

Download the full report: https://www.reportbuyer.com/product/4491939/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
 
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/site-specific-drug-delivery-market-by-application-pulmonary-ocular-oncology-cns-cardiovascular---world-forecasts-to-2022-300385083.html


'/>"/>
SOURCE ReportBuyer
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Drug and Gene Delivery Systems Market Worth $786.9 Billion by 2025: Grand View Research, Inc.
2. Research and Markets - Insulin Delivery Devices Market to Reach $19 Billion by 2025 - Key Vendors are Novo Nordisk, Sanofi & Biocon
3. Pulmatrix Receives Patents Important to its Inhaled Drug Delivery Technology
4. Animal Antibiotics and Antimicrobials Market by Product, Mode of Delivery, Animal - Global Forecast to 2021 -- Research and Markets
5. Transdermal Drug Delivery System - Global Market Outlook (2016-2022)
6. Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
7. Global Drug Delivery in Cancer Technologies, Markets and Companies Report 2016-2025: Profiles of 200+ Companies & 250+ Collaborations - Research and Markets
8. United States Lancet and Lancing Devices Market Report 2016-2017 with Diabetes Monitoring, Treatment And Drug Delivery Market Overview - Research and Markets
9. Emerus Continues Focus On Innovation In Healthcare Delivery With Adoption Of VeinViewer Technology
10. New Review of Novel Intranasal Delivery of Sumatriptan as a Route to Rapid and Sustained Relief in the Acute Treatment of Migraine
11. Global Transdermal Drug Delivery Report 2016: Technologies, Markets, and Companies Analysis & Forecasts to 2025 - Research and Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/14/2019)... ... September 13, 2019 , ... St. Joseph’s Hospital, Robins ... the structural topping out of the St. Joseph’s Hospital patient tower expansion located ... new six-story patient tower that will house a two-story lobby, waiting and on-call ...
(Date:9/12/2019)... ... ... Stratosphere Networks will sponsor GRIN2B Foundation’s first cocktail reception fundraiser, ... at Found Kitchen and Social House in Evanston from 6 p.m. to 9 p.m. ... is a gene on the short arm of the 12th chromosome and is part ...
(Date:9/11/2019)... ... 12, 2019 , ... Understanding the Drug Supply Chain Security ... Sept. 26, 2019, 1:30-3:00 p.m. EDT, https://www.fdanews.com/understanding-the-dscsa , Need to comply ... clear on nuances of the guidelines regulating the drug supply chain? , ...
Breaking Medicine Technology:
(Date:9/18/2019)... SCOTCH PLAINS, N.J. (PRWEB) , ... September 18, ... ... Michael L. Scagnelli, DMD for the fourth consecutive year. Dr. Scagnelli specializes in ... Matawan-based practice was established in the 1940’s and has been delivering quality dental ...
(Date:9/17/2019)... ... 17, 2019 , ... Six Consulting Inc. (SIX) recently announced ... – specifically golden retrievers - through innovative cancer prevention medicine. A national survey ... out of five retrievers in the United States will die from a particular ...
(Date:9/17/2019)... ... ... Lubin Austermuehle, P.C. will be one of the sponsors of GRIN2B ... Found Kitchen and Social House in Evanston on Monday, October 7 from 6 p.m. ... rare condition that results from changes to the GRIN2B gene. The GRIN2B gene is ...
(Date:9/17/2019)... LYNDHURST, N.J. (PRWEB) , ... September 17, 2019 ... ... in a wide array of services, welcomes Dr. Yevgeniya (Jenny) Gartshteyn to their ... University Medical Center, where she previously held the Clinical Appointment of Assistant Professor ...
(Date:9/11/2019)... ... September 12, 2019 , ... “Heart Seizures”: a useful source of ... disease as he hopes to prevent anyone from having it and to help those ... Saltwick, a writer who was diagnosed with coronary artery disease. Predicted to experience another ...
Breaking Medicine News(10 mins):